Dr. Cavagnaro’s professional focus is preclinical development and regulatory strategies for drug, biologics and device combinations. She is a Diplomate of the American Board of Toxicology (DABT), Fellow of the Academy of Toxicological Sciences (ATS), Regulatory Affairs Certification (RAC) Fellow of the Regulatory Affairs Professionals Society (RAPS), and president of Access BIO, a consultancy she founded that focuses on product development via science-based approaches.
Dr. Cavagnaro’s career spans academia, the Contract Research Organization (CRO) and biotechnology industries, and government, and she currently serves on SABs for countless organizations.